Phase I/II Study of BGB-290 with Temozolomide in Recurrent Gliomas with IDH1/2 Mutations

Grant

Date/time Interval

  • March 9, 2020 - March 8, 2021
  • Total Award Amount

  • 18000.00
  • Direct Costs

  • 12120.00
  • Sponsor Award Id

  • ABTC 1801
  • Contributor

  • Hassan Fathallah-Shaykh M.D., Ph.D.   Investigator  
  • Louis Nabors M.D.   Principal Investigator  
  • Mina Lobbous   Investigator  
  • Xiaosi Han   Investigator